Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
REC-617
i
Other names:
REC-617, GTAEXS617, GTAEXS-617, EXS 617, EXS617, EXS-617, REC617, REC 617
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Recursion Pharma
Drug class:
CDK7 inhibitor
Related drugs:
‹
YPN-005 (7)
SY‑079 (4)
SY-5609 (3)
CT7001 (3)
KRLS-017 (1)
Q901 (1)
EOC237 (0)
LY3405105 (0)
TGN-1062 (0)
TY-2699a (0)
XNW9015 (0)
SY-1365 (0)
AUR102 (0)
YPN-005 (7)
SY‑079 (4)
SY-5609 (3)
CT7001 (3)
KRLS-017 (1)
Q901 (1)
EOC237 (0)
LY3405105 (0)
TGN-1062 (0)
TY-2699a (0)
XNW9015 (0)
SY-1365 (0)
AUR102 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.